Misonix acquires Solsys Medical, LLC for $109 million

Client(s) Misonix, Inc.

Jones Day advised Misonix, Inc. in its acquisition of Solsys Medical, LLC, a privately held regenerative medical company, in an all-stock transaction valued at approximately $109 million. Misonix is currently traded on the NASDAQ Global Market. In the transaction, Misonix and Solsys Medical became subsidiaries of a new publicly traded holding company that is traded on the NASDAQ Global Market. Current shareholders of Misonix now own approximately 64% of the new holding company and current unitholders of Solsys now own approximately 36%. In connection with the transaction, Misonix entered into an amended and restated loan facility, drew additional funds under the facility, and expanded its future borrowing capacity.